Stefan Lonnberg
Overview
Explore the profile of Stefan Lonnberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
471
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Partanen V, Dillner J, Trope A, Agustsson A, Lonnberg S, Heinavaara S, et al.
Eur J Public Health
. 2024 Jan;
34(2):354-360.
PMID: 38261374
Background: Cervical cytology has been the primary method of cervical cancer screening for decades. Tests that detect viral HPV are shown in several randomized trials to provide better protection against...
2.
Baasland I, Vie G, Romundstad P, Lonnberg S
Acta Obstet Gynecol Scand
. 2022 Jun;
101(9):952-959.
PMID: 35689441
Introduction: The association between cervical cancer screening and reduction of cervical cancer has been dealt with in much research. However, little has been published on the association between screening and...
3.
Partanen V, Heinavaara S, Anttila A, Hakkarainen J, Lonnberg S
Acta Obstet Gynecol Scand
. 2022 Jan;
101(3):323-333.
PMID: 35040121
Introduction: The incidence of and mortality from cancers of the cervix uteri and corpus uteri are underestimated if the presence of uterine cancers, where the exact topography (site of origin)...
4.
Gravdal B, Lonnberg S, Skare G, Sulo G, Bjorge T
BMC Womens Health
. 2021 Mar;
21(1):110.
PMID: 33736628
Background: We compared women with incident cervical cancer under the age of 30 with older women with regard to stage, morphology, screening history and cervical cancer mortality in a population-based...
5.
Partanen V, Dillner J, Trope A, Agustsson A, Pankakoski M, Heinavaara S, et al.
J Med Screen
. 2021 Feb;
28(4):464-471.
PMID: 33563086
Objective: To compare primary test positivity in cytology and human papillomavirus-based screening between different Nordic cervical cancer screening programs using harmonized register data. Methods: This study utilized individual-level data available...
6.
Partanen V, Heinavaara S, Waldstrom M, Elfstrom K, Trope A, Agustsson A, et al.
Acta Oncol
. 2020 Sep;
59(11):1308-1315.
PMID: 32955963
Introduction: Screening has been the primary reason for the decline in the incidence and mortality of cervical cancer in the Nordic countries since the beginning of screening in the 1960s....
7.
Armaroli P, Riggi E, Basu P, Anttila A, Ponti A, Carvalho A, et al.
Int J Cancer
. 2020 Mar;
147(7):1855-1863.
PMID: 32159224
Comparable performance indicators for breast cancer screening in the European Union (EU) have not been previously reported. We estimated adjusted breast cancer screening positivity rate (PR) and detection rates (DR)...
8.
Ponti A, Basu P, Ritchie D, Anttila A, Carvalho A, Senore C, et al.
Int J Cancer
. 2020 Jan;
147(1):9-13.
PMID: 31970768
The 2003 European Council recommendation urging the Member States to introduce or scale up breast, cervical and colorectal cancer screening through an organized population-based approach has had a remarkable impact....
9.
Graue R, Lonnberg S, Skare G, Saether S, Bjorge T
Acta Obstet Gynecol Scand
. 2019 Dec;
99(5):582-590.
PMID: 31853943
Introduction: Cytology screening has been effective in reducing risks for cervical squamous cell carcinoma but less so for adenocarcinoma. We explored the association of atypical glandular cells or absence of...
10.
Vale D, Anttila A, Ponti A, Senore C, Sankaranaryanan R, Ronco G, et al.
Eur J Cancer Prev
. 2019 Aug;
28(5):458-459.
PMID: 31385844
No abstract available.